Latest in News & Research

Nonmelanoma Skin Cancers Larger Among Hispanic Patients

Mohs micrographic surgery defect sizes larger for Hispanic/Latino patients than for non-Hispanic White patients
By Physician’s Briefing Staff | | October 14, 2021

FDA Warns Against Using At-Home Dermal Filler 'Pens'

Serious adverse events have been reported in connection with dermal filler use, such as permanent damage to the skin, lips, and eyes
By Robert Preidt and Ernie Mundell (HealthDay News) | | October 14, 2021

What Predictors Differentiate ISK From SCC?

Dotted vessels, branched linear vessels, white structureless areas, white circle surrounding follicles predict SCC
By Dermsquared Editorial Team | | October 13, 2021

Does Abatacept Cut Psoriasis Relapse After Ustekinumab Withdrawal?

Similar proportion of patients who switched to abatacept and who continued ustekinumab had psoriasis relapse between weeks 12 and 88
By Dermsquared Editorial Team | | October 13, 2021

Infection Risk Does Not Seem to Differ Among Biologics for Psoriasis

Differential risk for serious infection or respiratory tract infection, including SARS-CoV-2, not seen among biologics used to treat psoriasis
By Physician's Briefing Staff | | October 08, 2021

No Causal Relationship Seen Between Allergic Disease, Mental Health

Mendelian randomization did not show evidence of causal effects between genetic risk for allergic disease and self-reported mental health
By Physician’s Briefing Staff | | October 07, 2021

COVID-19 Vaccine Concerns ID'd in Psoriasis, Psoriatic Arthritis Patients

Patient hesitancy stems from concerns about the safety of the vaccine and whether the vaccine would aggravate their underlying condition
By Physician’s Briefing Staff | | October 07, 2021

How Does Secukinumab Measure Up for Pediatric Patients With Plaque Psoriasis?

Both low and high secukinumab doses superior to historical placebo for PASI75/PASI90 and IGA0/1
By Dermsquared Editorial Team | | October 06, 2021

What Is the Efficacy of Ruxolitinib Versus Vehicle in Atopic Dermatitis?

Significantly more patients receiving ruxolitinib achieved investigator's global assessment treatment success, significant reduction of pruritus
By Dermsquared Editorial Team | | October 06, 2021

Use of Antihypertensive Drugs May Increase Risk for Psoriasis

Meta-analysis shows ACE inhibitors, ß-blockers, calcium-channel blockers, thiazide diuretics associated with increased risk for psoriasis
By Physician’s Briefing Staff | | October 06, 2021

Johnson & Johnson Seeks FDA Emergency Approval for Its Booster Shot

FDA advisory panel will review J&J data next week and vote on whether to recommend boosters
By Physician's Briefing Staff | | October 05, 2021

Study Confirms Virulence of SARS-CoV-2 Variants of Concern

Risks for hospitalization, ICU admission, death up for N501Y-positive variants; even more pronounced with delta variant
By Physician’s Briefing Staff | | October 05, 2021

Incidence of Keratinocyte Carcinoma Up From 2003 to 2017

Incidence rate higher for women younger than 55 years and for men aged 55 years and older; mortality higher for men
By Physician's Briefing Staff | | October 04, 2021

Scientists Share Nobel Prize for Discoveries That Changed Pain Research

The two scientists have helped answer one of the most profound questions about the human condition: How do we sense our environment?
By Physician’s Briefing Staff | | October 04, 2021

Chronic Spontaneous Urticaria Differs in Children, Adults

Incidence of angioedema, thyroid autoimmunity associated with chronic spontaneous urticaria lower for children than adults
By Physician’s Briefing Staff | | October 04, 2021

Is There a Laterality Preference for Lentigo Maligna, LM Melanoma?

Although no laterality preference found overall, neoplasms on head/neck show left-sided laterality; LM, LMM incidence highest on head/neck
By Dermsquared Editorial Team | | September 29, 2021

Recommendations Made for Treatment of Actinic Keratoses

Use of UV protection recommended; field treatment recommended with topical agents 5-FU and imiquimod
By Dermsquared Editorial Team | | September 29, 2021

Taxane-Containing Chemo Associated With Persistent Alopecia

However, many patients experience improvements in hair density with standard alopecia treatments
By Physician’s Briefing Staff | | September 29, 2021

FDA Takes New Action to Improve Quality, Efficacy of Sunscreens

Proposed changes include updates to safe active ingredients and broad spectrum requirements
By Physician’s Briefing Staff | | September 29, 2021

Live Attenuated Zoster Vaccine Safe for Patients Receiving TNF Inhibitors

No cases of varicella infection found; cumulative incidence of varicella infection or shingles was 0 percent
By Physician's Briefing Staff | | September 27, 2021

Survival Up With Tebentafusp in Metastatic Uveal Melanoma

Overall survival longer with tebentafusp for HLA*02:01-positive patients with previously untreated metastatic uveal melanoma
By Physician’s Briefing Staff | | September 23, 2021

HPV Vaccine Will Have Modest Impact on Oropharynx Cancer Incidence by 2045

However, reductions in oropharynx cancer incidence should be seen among young and middle-aged adults
By Physician's Briefing Staff | | September 23, 2021

Has There Been a Drop in Opioid Prescriptions After Mohs Surgery?

Use of hydrocodone decreased from 2011 to 2020, while use of tramadol increased from 2009 to 2020
By Dermsquared Editorial Team | | September 22, 2021

24 of 1200

Headline from the Week of February 09 - 15, 2026

Second Annual National Cancer Database Report Presented for 2022

By Elana Gotkine (HealthDay News) | | February 11, 2026

Presurgical Pembrolizumab Beneficial for Desmoplastic Melanoma

By Elana Gotkine (HealthDay News) | | February 11, 2026